Stents - Market Insights, Competitive Landscape and Market Forecast-2027
This report can be delivered to the clients within 7-10 Business Days
Stents Market By Product Type (Coronary, Venous, Biliary, Peripheral And Others), By Material Type (Polymer, Alloy And Metal), By Type (Self-Expanding And Balloon-Expandable Stents), By End-User Type (Hospitals And Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to increasing prevalence of chronic diseases and rise in geriatric population.
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2022 to 2027. The stents market is witnessing a positive growth owing to the factors such as increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, thereby all factors contributing to the growth of stents market during the forecast period from 2022-2027.
Stents Market Dynamics:
One of the main drivers of the stents market is the increasing prevalence of chronic diseases. Furthermore, the rise in the prevalence of chronic diseases will lead to an increase in the mortality rate among the patient population globally. For instance, according to the dada published by World Health Organization (WHO) in 2021, each year 41 million or 71% deaths globally takes place due to chronic diseases. Further, it is estimated that 15 million people aged 30-69 years die each year, 17.9 million die due to cardiovascular diseases annually, followed by cancer (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). All these four diseases account for over 80% of all chronic deaths. People living with diabetes are more prone to cardiovascular diseases such as coronary artery disease, heart attack, and others. Moreover, stents can be used to treat cancers such as stomach, lung and others as well as respiratory and cardiovascular diseases. Therefore, owing to a rise in the prevalence of these chronic diseases, the death rate is also increasing significantly. Thus, by providing the treatment with the help of stents, the mortality rate that is increasing as a result of chronic diseases can also be minimized, thereby driving the demand and growth of stents market.
Moreover, another key factor which is responsible for the growth of stents market is rise in geriatric population, according to World Health Organization (WHO) October 2021 data, it was estimated that between year 2015-2050 people of age 60 and above will be doubled from 12-22% and will reach 2.1 billion by 2050. Further, by 2030, 1 in 6 people in the world will age 60 years or above. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, rise in geriatric population will lead to rise in chronic diseases as this population have more chances of getting diseases such as coronary artery diseases and others which require implantation of stents as their treatment solution, which can enhance the growth of stents market as the demand will rise.
However, stringent regulatory approvals for stents and complications associated with implantation of stents can slow down the stents market growth.
Additionally, the ongoing COVID-19 pandemic has negatively impacted the stents market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing rate due to which there was product shortage in the market, elective surgeries were not given priority as COVID-19 patients were given more preference in terms of treatment. For instance, as per the American Hospital Association 2020, in between March and June 2020, there had been an estimated loss of USD 50.7 billion to the United States hospitals as a result of the reduction observed in “elective” procedures including stents implantation. As per the same source, on an average these procedures had accounted to about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, increase in the elective surgeries, the stents market has picked momentum and is expected to further grow during the forecast period.
Stents Market Segment Analysis:
Stents market by Product Type (Coronary, Venous, Biliary and Peripheral, Others), by Material Type (Polymer, Alloy and Metal ), by Type (Self-Expanding and Balloon-Expandable Stents), by End-User Type (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In by product type segment of stents market, coronary stents are estimated to hold highest share in year 2021, to avoid the heart attack which is caused due to blockage of coronary arteries, stents can be introduced to treat blocked arteries. According to WHO 2021 data, in 2019 approximately 17.9 million people died due to cardiovascular diseases globally. Out of 17 million premature death (people of age under 70), 38% deaths were caused due to cardiovascular diseases. Therefore, due to increasing prevalence of cardiovascular diseases, death rate is also increasing. Thus, providing treatment with the help of coronary stents, mortality rate due to these cardiovascular diseases can be limited, this induces the growth of coronary stents market leading to the growth of overall stents market forcast during (2022-2027).
The rising approval and launch of coronary stent will alos promote the demand of stents, leading to an overall growth of the stents market, for instance, in September 2021, BIOTRONIK, a leading medical device company, announced U.S. Food and Drug Administration (FDA) approval of its Orsiro® mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES) in the US.
Therefore, increasing prevalence of cardiovascular diseases and approval & launch of coronary stents, increases the stents demand thereby, driving the growth of the overall stents market during the forecast period from 2022-2027.
North America is expected to dominate the overall Stents Market:
Among all the regions, North America is estimated to dominate the global stents market in the year 2021 and is expected to do the same during the forecast period from 2022-2027. Factors such as rising prevalence of sedentary lifestyle and rising technological advancements associated with the stents increases the stents market in North America.
According to Centers For Disease Control and Prevention (CDC) January 2022 data, in 2021, 25% of the US adults population were found to be physically inactive. In 2020, more then 15% adults were physically inactive. Therefore, rising prevalence of sedentary lifestyle enhance the risk of developing diseases such as diabetes, cancer and others among the US population which require stents as a treatment solution ultimately increase the demand of stents thereby, propelling the growth of stents market in North America.
Furthermore, technological advancements also driving the growth of stents market. For instance, in August 2019, FDA approved treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents are approved to treat obstructed lesions in arteries of the legs.
Further, in January 2020, FDA Approved 3D-printed airway stents developed by Cleveland Clinic doctor, these stents are used to keep the airways open of patients having serious disorders, such as tumors, inflammation, trauma or other masses.
Thus, all above mentioned factors wil surge the demand of stents thereby, driving the growth of the overall stents market during the forecast period from 2022-2027.
Stents Market Key Players:
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
Recent Developmental Activities in the Stents Market:
1. What are Stents?
Stents are tiny metal or plastic tubes which are inserted in a blocked passageway to keep it open. Depending on where it is placed stent restores the flow of blood or other fluids.
2. What is the market for Global Stents?
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2022 to 2027.
3. What are the drivers for the Global Stents Market?
The stents market is witnessing a positive market growth owing to the factors such as, increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, surge in sedentary lifestyle, technological advancements in product offerings.
4. Who are the key players operating in the Stents Market?
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
5. Which region has the highest share in Stents Market?
North America is estimated to dominate the global stents market. Factors contributing to the growth of stents market includes rising prevalence of sedentary lifestyle, increasing product approval in the region, and rising technological advancements associated with the stents are drivgn the North America stents market. ?
Stents Market By Product Type (Coronary, Venous, Biliary, Peripheral And Others), By Material Type (Polymer, Alloy And Metal), By Type (Self-Expanding And Balloon-Expandable Stents), By End-User Type (Hospitals And Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to increasing prevalence of chronic diseases and rise in geriatric population.
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2022 to 2027. The stents market is witnessing a positive growth owing to the factors such as increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, thereby all factors contributing to the growth of stents market during the forecast period from 2022-2027.
Stents Market Dynamics:
One of the main drivers of the stents market is the increasing prevalence of chronic diseases. Furthermore, the rise in the prevalence of chronic diseases will lead to an increase in the mortality rate among the patient population globally. For instance, according to the dada published by World Health Organization (WHO) in 2021, each year 41 million or 71% deaths globally takes place due to chronic diseases. Further, it is estimated that 15 million people aged 30-69 years die each year, 17.9 million die due to cardiovascular diseases annually, followed by cancer (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). All these four diseases account for over 80% of all chronic deaths. People living with diabetes are more prone to cardiovascular diseases such as coronary artery disease, heart attack, and others. Moreover, stents can be used to treat cancers such as stomach, lung and others as well as respiratory and cardiovascular diseases. Therefore, owing to a rise in the prevalence of these chronic diseases, the death rate is also increasing significantly. Thus, by providing the treatment with the help of stents, the mortality rate that is increasing as a result of chronic diseases can also be minimized, thereby driving the demand and growth of stents market.
Moreover, another key factor which is responsible for the growth of stents market is rise in geriatric population, according to World Health Organization (WHO) October 2021 data, it was estimated that between year 2015-2050 people of age 60 and above will be doubled from 12-22% and will reach 2.1 billion by 2050. Further, by 2030, 1 in 6 people in the world will age 60 years or above. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, rise in geriatric population will lead to rise in chronic diseases as this population have more chances of getting diseases such as coronary artery diseases and others which require implantation of stents as their treatment solution, which can enhance the growth of stents market as the demand will rise.
However, stringent regulatory approvals for stents and complications associated with implantation of stents can slow down the stents market growth.
Additionally, the ongoing COVID-19 pandemic has negatively impacted the stents market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing rate due to which there was product shortage in the market, elective surgeries were not given priority as COVID-19 patients were given more preference in terms of treatment. For instance, as per the American Hospital Association 2020, in between March and June 2020, there had been an estimated loss of USD 50.7 billion to the United States hospitals as a result of the reduction observed in “elective” procedures including stents implantation. As per the same source, on an average these procedures had accounted to about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, increase in the elective surgeries, the stents market has picked momentum and is expected to further grow during the forecast period.
Stents Market Segment Analysis:
Stents market by Product Type (Coronary, Venous, Biliary and Peripheral, Others), by Material Type (Polymer, Alloy and Metal ), by Type (Self-Expanding and Balloon-Expandable Stents), by End-User Type (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In by product type segment of stents market, coronary stents are estimated to hold highest share in year 2021, to avoid the heart attack which is caused due to blockage of coronary arteries, stents can be introduced to treat blocked arteries. According to WHO 2021 data, in 2019 approximately 17.9 million people died due to cardiovascular diseases globally. Out of 17 million premature death (people of age under 70), 38% deaths were caused due to cardiovascular diseases. Therefore, due to increasing prevalence of cardiovascular diseases, death rate is also increasing. Thus, providing treatment with the help of coronary stents, mortality rate due to these cardiovascular diseases can be limited, this induces the growth of coronary stents market leading to the growth of overall stents market forcast during (2022-2027).
The rising approval and launch of coronary stent will alos promote the demand of stents, leading to an overall growth of the stents market, for instance, in September 2021, BIOTRONIK, a leading medical device company, announced U.S. Food and Drug Administration (FDA) approval of its Orsiro® mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES) in the US.
Therefore, increasing prevalence of cardiovascular diseases and approval & launch of coronary stents, increases the stents demand thereby, driving the growth of the overall stents market during the forecast period from 2022-2027.
North America is expected to dominate the overall Stents Market:
Among all the regions, North America is estimated to dominate the global stents market in the year 2021 and is expected to do the same during the forecast period from 2022-2027. Factors such as rising prevalence of sedentary lifestyle and rising technological advancements associated with the stents increases the stents market in North America.
According to Centers For Disease Control and Prevention (CDC) January 2022 data, in 2021, 25% of the US adults population were found to be physically inactive. In 2020, more then 15% adults were physically inactive. Therefore, rising prevalence of sedentary lifestyle enhance the risk of developing diseases such as diabetes, cancer and others among the US population which require stents as a treatment solution ultimately increase the demand of stents thereby, propelling the growth of stents market in North America.
Furthermore, technological advancements also driving the growth of stents market. For instance, in August 2019, FDA approved treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents are approved to treat obstructed lesions in arteries of the legs.
Further, in January 2020, FDA Approved 3D-printed airway stents developed by Cleveland Clinic doctor, these stents are used to keep the airways open of patients having serious disorders, such as tumors, inflammation, trauma or other masses.
Thus, all above mentioned factors wil surge the demand of stents thereby, driving the growth of the overall stents market during the forecast period from 2022-2027.
Stents Market Key Players:
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
Recent Developmental Activities in the Stents Market:
- In June 2021, Abbott, a global healthcare leader announced its XIENCE family of stents has received FDA approval for one-month DAPT labeling for high bleeding risk (HBR) patients in the U.S
- In October 2020, Medtronic plc, a global leader in medical technology, announced that it has received FDA approval for the Abre™ venous self-expanding stent system in U.S for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction
- In March 2019, BD, a leading global medical technology company, received U.S. FDA premarket approval for first venous stent to treat iliofemoral venous occlusive disease
- Market size analysis for current stents market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the stents.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global stents.
- Various opportunities available for the other competitor in the stents market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current stents market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for stents market growth in the coming future?
- Stents products providers
- Research organizations and consulting companies
- Stents-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in stents
- Various End-users who want to know more about the stents market and latest technological developments in the stents
1. What are Stents?
Stents are tiny metal or plastic tubes which are inserted in a blocked passageway to keep it open. Depending on where it is placed stent restores the flow of blood or other fluids.
2. What is the market for Global Stents?
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2022 to 2027.
3. What are the drivers for the Global Stents Market?
The stents market is witnessing a positive market growth owing to the factors such as, increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, surge in sedentary lifestyle, technological advancements in product offerings.
4. Who are the key players operating in the Stents Market?
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
5. Which region has the highest share in Stents Market?
North America is estimated to dominate the global stents market. Factors contributing to the growth of stents market includes rising prevalence of sedentary lifestyle, increasing product approval in the region, and rising technological advancements associated with the stents are drivgn the North America stents market. ?
1.STENTS MARKET REPORT INTRODUCTION
2.STENTS MARKET EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. REGULATORY ANALYSIS
3.1. The US
3.2. Europe
3.3. Japan
3.4. China
4. STENTS MARKET KEY FACTORS ANALYSIS
4.1. Stents Market Drivers
4.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Rise in Geriatric Population
4.1.3. Rising Technological Advancements Associated with the Stents
4.1.4. Rising Prevalence of Sedentary Lifestyle
4.2. Stents Market Restraints And Challenges
4.2.1. Stringent Regulatory Approvals for Stents
4.2.2. Complications Associated With Implantation of Stents
4.3. Stents Market Opportunities
4.3.1. Growing Demand of Drug-Eluting Stents
4.3.2. 3D Printing Advancements in Development of Stents
5. STENTS MARKET PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON STENTS MARKET
7. STENTS MARKET LAYOUT
7.1. By Product Type
7.1.1. Coronary
7.1.2. Venous
7.1.3. Biliary
7.1.4. Peripheral
7.1.5. Others
7.2. By Material Type
7.2.1. Polymer
7.2.2. Alloy
7.2.3. Metal
7.3. By Type
7.3.1. Self-Expanding Stents
7.3.2. Balloon-Expanding Stents
7.4. By End User Type
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Others
7.5. By Geography
7.5.1. North America
7.5.1.1. North America Stents Market, by Country
7.5.1.1.1. US
7.5.1.1.2. Canada
7.5.1.1.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Stents Market, by Country
7.5.2.1.1. France
7.5.2.1.2. Germany
7.5.2.1.3. United Kingdom
7.5.2.1.4. Italy
7.5.2.1.5. Spain
7.5.2.1.6. Russia
7.5.2.1.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Stents Market, by Country
7.5.3.1.1. China
7.5.3.1.2. Japan
7.5.3.1.3. India
7.5.3.1.4. Australia
7.5.3.1.5. South Korea
7.5.3.1.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. RoW Stents Market, by Region
7.5.4.1.1. Middle East
7.5.4.1.2. Africa
7.5.4.1.3. South America
8. STENTS MARKET GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES
9. STENTS MARKET COMPANY AND PRODUCT PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. BD
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. Medtronic
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. Abbott
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. Cook
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Merit Medical Systems
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Novatech SA
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Terumo Europe NV
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. MicroPort Scientific Corporation
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Fuji Systems Corp
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. MICRO-TECH EUROPE
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Vascular Concepts
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Olympus America
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. W. L. Gore & Associates Inc
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. B. Braun Melsungen AG
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. BIOTRONIK SE & Co. KG
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. Teleflex Incorporated
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. Elixir Medical Corporation
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. REVA Medical, LLC,
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
10. KOL VIEWS
11. PROJECT APPROACH
12. ABOUT DELVEINSIGHT
13. DISCLAIMER & CONTACT US
2.STENTS MARKET EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. REGULATORY ANALYSIS
3.1. The US
3.2. Europe
3.3. Japan
3.4. China
4. STENTS MARKET KEY FACTORS ANALYSIS
4.1. Stents Market Drivers
4.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Rise in Geriatric Population
4.1.3. Rising Technological Advancements Associated with the Stents
4.1.4. Rising Prevalence of Sedentary Lifestyle
4.2. Stents Market Restraints And Challenges
4.2.1. Stringent Regulatory Approvals for Stents
4.2.2. Complications Associated With Implantation of Stents
4.3. Stents Market Opportunities
4.3.1. Growing Demand of Drug-Eluting Stents
4.3.2. 3D Printing Advancements in Development of Stents
5. STENTS MARKET PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON STENTS MARKET
7. STENTS MARKET LAYOUT
7.1. By Product Type
7.1.1. Coronary
7.1.2. Venous
7.1.3. Biliary
7.1.4. Peripheral
7.1.5. Others
7.2. By Material Type
7.2.1. Polymer
7.2.2. Alloy
7.2.3. Metal
7.3. By Type
7.3.1. Self-Expanding Stents
7.3.2. Balloon-Expanding Stents
7.4. By End User Type
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Others
7.5. By Geography
7.5.1. North America
7.5.1.1. North America Stents Market, by Country
7.5.1.1.1. US
7.5.1.1.2. Canada
7.5.1.1.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Stents Market, by Country
7.5.2.1.1. France
7.5.2.1.2. Germany
7.5.2.1.3. United Kingdom
7.5.2.1.4. Italy
7.5.2.1.5. Spain
7.5.2.1.6. Russia
7.5.2.1.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Stents Market, by Country
7.5.3.1.1. China
7.5.3.1.2. Japan
7.5.3.1.3. India
7.5.3.1.4. Australia
7.5.3.1.5. South Korea
7.5.3.1.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. RoW Stents Market, by Region
7.5.4.1.1. Middle East
7.5.4.1.2. Africa
7.5.4.1.3. South America
8. STENTS MARKET GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES
9. STENTS MARKET COMPANY AND PRODUCT PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. BD
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. Medtronic
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. Abbott
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. Cook
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Merit Medical Systems
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Novatech SA
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Terumo Europe NV
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. MicroPort Scientific Corporation
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Fuji Systems Corp
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. MICRO-TECH EUROPE
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Vascular Concepts
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Olympus America
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. W. L. Gore & Associates Inc
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. B. Braun Melsungen AG
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. BIOTRONIK SE & Co. KG
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. Teleflex Incorporated
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. Elixir Medical Corporation
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. REVA Medical, LLC,
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
10. KOL VIEWS
11. PROJECT APPROACH
12. ABOUT DELVEINSIGHT
13. DISCLAIMER & CONTACT US
LIST OF TABLES
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Stents Market in Global (2019-2027)
Table 4: Stents Market in Global by Product Type (2019-2027)
Table 5: Stents Market in Global by Material Type (2019-2027)
Table 6: Stents Market in Global by Type (2019-2027)
Table 7: Stents Market in Global by End User (2019-2027)
Table 8: Stents Market in Global by Geography (2019-2027)
Table 9: Stents Market in North America (2019-2027)
Table 10: Stents Market in North America by Country (2019-2027)
Table 11: Stents Market in the US (2019-2027)
Table 12: Stents Market in Canada (2019-2027)
Table 13: Stents Market in Mexico (2019-2027)
Table 14: Stents Market in Europe (2019-2027)
Table 15: Stents Market in Europe by Country (2019-2027)
Table 16: Stents Market in France (2019-2027)
Table 17: Stents Market in Germany (2019-2027)
Table 18: Stents Market in the United Kingdom (2019-2027)
Table 19: Stents Market in Italy (2019-2027)
Table 20: Stents Market in Spain (2019-2027)
Table 21: Stents Market in Russia (2019-2027)
Table 22: Stents Market in Rest of Europe (2019-2027)
Table 23: Stents Market in APAC (2019-2027)
Table 24: Stents Market in APAC by Country (2019-2027)
Table 25: Stents Market in China (2019-2027)
Table 26: Stents Market in Japan (2019-2027)
Table 27: Stents Market in India (2019-2027)
Table 28: Stents Market in Australia (2019-2027)
Table 29: Stents Market in South Korea (2019-2027)
Table 30: Stents Market in Rest of APAC (2019-2027)
Table 31: Stents Market in Rest of World (2019-2027)
Table 32: Stents Market in RoW by Region (2019-2027)
Table 33: Stents Market in Middle East (2019-2027)
Table 34: Stents Market in Africa (2019-2027)
Table 35: Stents Market in South America (2019-2027)
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Stents Market in Global (2019-2027)
Table 4: Stents Market in Global by Product Type (2019-2027)
Table 5: Stents Market in Global by Material Type (2019-2027)
Table 6: Stents Market in Global by Type (2019-2027)
Table 7: Stents Market in Global by End User (2019-2027)
Table 8: Stents Market in Global by Geography (2019-2027)
Table 9: Stents Market in North America (2019-2027)
Table 10: Stents Market in North America by Country (2019-2027)
Table 11: Stents Market in the US (2019-2027)
Table 12: Stents Market in Canada (2019-2027)
Table 13: Stents Market in Mexico (2019-2027)
Table 14: Stents Market in Europe (2019-2027)
Table 15: Stents Market in Europe by Country (2019-2027)
Table 16: Stents Market in France (2019-2027)
Table 17: Stents Market in Germany (2019-2027)
Table 18: Stents Market in the United Kingdom (2019-2027)
Table 19: Stents Market in Italy (2019-2027)
Table 20: Stents Market in Spain (2019-2027)
Table 21: Stents Market in Russia (2019-2027)
Table 22: Stents Market in Rest of Europe (2019-2027)
Table 23: Stents Market in APAC (2019-2027)
Table 24: Stents Market in APAC by Country (2019-2027)
Table 25: Stents Market in China (2019-2027)
Table 26: Stents Market in Japan (2019-2027)
Table 27: Stents Market in India (2019-2027)
Table 28: Stents Market in Australia (2019-2027)
Table 29: Stents Market in South Korea (2019-2027)
Table 30: Stents Market in Rest of APAC (2019-2027)
Table 31: Stents Market in Rest of World (2019-2027)
Table 32: Stents Market in RoW by Region (2019-2027)
Table 33: Stents Market in Middle East (2019-2027)
Table 34: Stents Market in Africa (2019-2027)
Table 35: Stents Market in South America (2019-2027)
LIST OF FIGURES
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis
Figure 3: Stents Market in Global (2019-2027)
Figure 4: Stents Market in Global by Product Type (2019-2027)
Figure 5: Stents Market in Global by Material Type (2019-2027)
Figure 6: Stents Market in Global by Type (2019-2027)
Figure 7: Stents Market in Global by End User (2019-2027)
Figure 8: Stents Market in Global by Geography (2019-2027)
Figure 9: Stents Market in North America (2019-2027)
Figure 10: Stents Market in North America by Country (2019-2027)
Figure 11: Stents Market in the US (2019-2027)
Figure 12: Stents Market in Canada (2019-2027)
Figure 13: Stents Market in Mexico (2019-2027)
Figure 14: Stents Market in Europe (2019-2027)
Figure 15: Stents Market in Europe by Country (2019-2027)
Figure 16: Stents Market in France (2019-2027)
Figure 17: Stents Market in Germany (2019-2027)
Figure 18: Stents Market in the United Kingdom (2019-2027)
Figure 19: Stents Market in Italy (2019-2027)
Figure 20: Stents Market in Spain (2019-2027)
Figure 21: Stents Market in Russia (2019-2027)
Figure 22: Stents Market in Rest of Europe (2019-2027)
Figure 23: Stents Market in APAC (2019-2027)
Figure 24: Stents Market in APAC by Country (2019-2027)
Figure 25: Stents Market in China (2019-2027)
Figure 26: Stents Market in Japan (2019-2027)
Figure 27: Stents Market in India (2019-2027)
Figure 28: Stents Market in Australia (2019-2027)
Figure 29: Stents Market in South Korea (2019-2027)
Figure 30: Stents Market in Rest of APAC (2019-2027)
Figure 31: Stents Market in Rest of World (2019-2027)
Figure 32: Stents Market in RoW by Region (2019-2027)
Figure 33: Stents Market in Middle East (2019-2027)
Figure 34: Stents Market in Africa (2019-2027)
Figure 35: Stents Market in South America (2019-2027)
Figure 36: Market Drivers
Figure 37: Market Barriers
Figure 38: Marker Opportunities
Figure 38: PORTER'S Five Force Analysis
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis
Figure 3: Stents Market in Global (2019-2027)
Figure 4: Stents Market in Global by Product Type (2019-2027)
Figure 5: Stents Market in Global by Material Type (2019-2027)
Figure 6: Stents Market in Global by Type (2019-2027)
Figure 7: Stents Market in Global by End User (2019-2027)
Figure 8: Stents Market in Global by Geography (2019-2027)
Figure 9: Stents Market in North America (2019-2027)
Figure 10: Stents Market in North America by Country (2019-2027)
Figure 11: Stents Market in the US (2019-2027)
Figure 12: Stents Market in Canada (2019-2027)
Figure 13: Stents Market in Mexico (2019-2027)
Figure 14: Stents Market in Europe (2019-2027)
Figure 15: Stents Market in Europe by Country (2019-2027)
Figure 16: Stents Market in France (2019-2027)
Figure 17: Stents Market in Germany (2019-2027)
Figure 18: Stents Market in the United Kingdom (2019-2027)
Figure 19: Stents Market in Italy (2019-2027)
Figure 20: Stents Market in Spain (2019-2027)
Figure 21: Stents Market in Russia (2019-2027)
Figure 22: Stents Market in Rest of Europe (2019-2027)
Figure 23: Stents Market in APAC (2019-2027)
Figure 24: Stents Market in APAC by Country (2019-2027)
Figure 25: Stents Market in China (2019-2027)
Figure 26: Stents Market in Japan (2019-2027)
Figure 27: Stents Market in India (2019-2027)
Figure 28: Stents Market in Australia (2019-2027)
Figure 29: Stents Market in South Korea (2019-2027)
Figure 30: Stents Market in Rest of APAC (2019-2027)
Figure 31: Stents Market in Rest of World (2019-2027)
Figure 32: Stents Market in RoW by Region (2019-2027)
Figure 33: Stents Market in Middle East (2019-2027)
Figure 34: Stents Market in Africa (2019-2027)
Figure 35: Stents Market in South America (2019-2027)
Figure 36: Market Drivers
Figure 37: Market Barriers
Figure 38: Marker Opportunities
Figure 38: PORTER'S Five Force Analysis
